| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2c74e1f288917b6085d1e32c3d76caf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f754fd795dc6b56d4d89fd74562d3d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bb71248545f234c5e4e374256cba6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate |
2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70c420d5f6f683bcdaa95c3c8d9658f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1737f3f447389d218636b56c2507b45 |
| publicationDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8592169-B2 |
| titleOfInvention |
Tumour marker proteins and uses thereof |
| abstract |
The invention relates to tumor marker proteins and their preparation from fluids from one or more cancer patients, wherein said fluids are those which collect in a body cavity or space which is naturally occurring or which is the result of cancer or medical intervention for cancer. The invention also relates to preparation of tumor marker proteins from excretions taken from patients with cancer. The tumor marker proteins are useful as immunoassay reagents in the detection of cancer-associated anti-tumor marker autoantibodies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008108084-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9719984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9714938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9696319-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11307203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9267133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9658231-B2 |
| priorityDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |